Brca Mutations News Today

Patients with prostate cancer may have an inherited or acquired BRCA mutation, and both can have treatment implications, an expert said.

The recommended phase 2 dose of olaparib plus selumetinib generated a clinical benefit in patients with endometrial or ovarian cancer harboring RAS mutations, according to findings from the dose-expansion portion of the phase 1b SOLAR trial.

Nearly 20,000 women will receive a new diagnosis of ovarian cancer this year and more than 12,000 will die from the disease. Dr. Carol Brown, a gynecologic cancer surgeon and chief health equity officer at Memorial Sloan Kettering Cancer Center, joined Amna Nawaz to discuss who should consider themselves at the greatest risk of ovarian cancer.